These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29929194)

  • 1. Statins and Thyroid Carcinoma: a Meta-Analysis.
    Zhao J; Xu C; Yao J; Yu C; Liao L; Dong J
    Cell Physiol Biochem; 2018; 47(4):1422-1431. PubMed ID: 29929194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of statins in thyroid proliferative disease.
    Bifulco M
    Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):242-3. PubMed ID: 18301396
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
    Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
    Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
    Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins sentence thyroid cancer cells to death rho.
    Robbins RJ
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3019-20. PubMed ID: 12843137
    [No Abstract]   [Full Text] [Related]  

  • 6. Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma.
    Zhou YY; Zhu GQ; Wang Y; Zheng JN; Ruan LY; Cheng Z; Hu B; Fu SW; Zheng MH
    Oncotarget; 2016 Apr; 7(16):21753-62. PubMed ID: 26943041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of c-Jun N-terminal kinase is required for mevastatin-induced apoptosis of salivary adenoid cystic carcinoma cells.
    Zhang S; Wang XL; Gan YH; Li SL
    Anticancer Drugs; 2010 Aug; 21(7):678-86. PubMed ID: 20629200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
    Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
    Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression.
    Kah J; Wüstenberg A; Keller AD; Sirma H; Montalbano R; Ocker M; Volz T; Dandri M; Tiegs G; Sass G
    Oncol Rep; 2012 Sep; 28(3):1077-83. PubMed ID: 22710979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of statins and exercise combination therapy compared to statin monotherapy in patients with dyslipidaemia: A systematic review and meta-analysis.
    Gui YJ; Liao CX; Liu Q; Guo Y; Yang T; Chen JY; Wang YT; Hu JH; Xu DY
    Eur J Prev Cardiol; 2017 Jun; 24(9):907-916. PubMed ID: 28436720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential antitumor effects of statins (Review).
    Jakobisiak M; Golab J
    Int J Oncol; 2003 Oct; 23(4):1055-69. PubMed ID: 12963986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis.
    Wong WW; Dimitroulakos J; Minden MD; Penn LZ
    Leukemia; 2002 Apr; 16(4):508-19. PubMed ID: 11960327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins in tumor suppression.
    Sassano A; Platanias LC
    Cancer Lett; 2008 Feb; 260(1-2):11-9. PubMed ID: 18180097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of statin therapy on colorectal cancer.
    Bardou M; Barkun A; Martel M
    Gut; 2010 Nov; 59(11):1572-85. PubMed ID: 20660702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins in oncological research: from experimental studies to clinical practice.
    Kubatka P; Kruzliak P; Rotrekl V; Jelinkova S; Mladosievicova B
    Crit Rev Oncol Hematol; 2014 Dec; 92(3):296-311. PubMed ID: 25220658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin use and the overall survival of renal cell carcinoma: A meta-analysis.
    Wu P; Xiang T; Wang J; Lv R; Zhuang Y; Wu G
    Clin Invest Med; 2020 Dec; 43(4):E17-23. PubMed ID: 33370521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer.
    Graaf MR; Richel DJ; van Noorden CJ; Guchelaar HJ
    Cancer Treat Rev; 2004 Nov; 30(7):609-41. PubMed ID: 15531395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of statins for osteoporosis: a systematic review and meta-analysis.
    An T; Hao J; Sun S; Li R; Yang M; Cheng G; Zou M
    Osteoporos Int; 2017 Jan; 28(1):47-57. PubMed ID: 27888285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of statins on gastric cancer incidence: a meta-analysis of case control studies.
    Ma Z; Wang W; Jin G; Chu P; Li H
    J Cancer Res Ther; 2014; 10(4):859-65. PubMed ID: 25579519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Statins on Renal Outcome in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis.
    Sanguankeo A; Upala S; Cheungpasitporn W; Ungprasert P; Knight EL
    PLoS One; 2015; 10(7):e0132970. PubMed ID: 26151753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.